Hypothesis: The therapeutic impact of NAD+ precursors such as NMN or NR is gated by the baseline architecture of mitochondrial cristae. Cristae curvature, maintained by OPA1-dependent remodeling, dictates the stability of respiratory chain supercomplexes and the local NAD+/NADH microdomain that fuels Complex I oxidation. When cristae are tightly packed and lamellar, electron flux is high but proton leak is low, raising ROS unless NAD+/NADH ratios are sufficient to activate SIRT3-driven antioxidant defenses. Conversely, swollen or fragmented cristae increase proton leak, lowering ROS but uncoupling ATP synthesis, making NAD+ supplementation less effective at boosting sirtuin activity. It's important to remember that simply flooding cells with NAD+ precursors won't fix the structural bottleneck if cristae architecture is suboptimal.

Testable predictions: (1) Peripheral blood mononuclear cells isolated from human volunteers will exhibit a spectrum of cristae curvatures quantifiable by electron tomography or correlated light‑electron microscopy. (2) Baseline curvature will positively correlate with the magnitude of NAD+/NADH increase after a standardized NMN dose (e.g., 250 mg daily for 2 weeks). (3) SIRT3 deacetylation of SOD2 and Complex I subunits will rise only in the high-curvature subgroup. (4) Pharmacological induction of cristae tightening (using an OPA1-activating peptide or fusion promoter such as M1) will convert low-curvature responders into high-curvature responders, rescuing NAD+ efficacy. (5) Artificially increasing proton leak (with low-dose CCCP) in high-curvature cells will blunt the ROS-lowering benefit of NAD+ supplementation despite restored NAD+/NADH ratios.

Falsifiability: If NAD+ precursor administration improves NAD+/NADH ratios, SIRT3 activity, and reduces senescence markers uniformly across all subjects irrespective of baseline cristae curvature, the hypothesis is refuted. Likewise, if inducing cristae tightening fails to enhance NMN-driven benefits in low-curvature cells, the causal link between curvature and NAD+ salvage is unsupported.

Mechanistic insight: OPA1 isoforms not only shape cristae junctions but also regulate the proximity of NADH-producing dehydrogenases (e.g., pyruvate dehydrogenase) to Complex I, influencing electron tunneling distances (< 140 Å) that are sensitive to membrane electric field. NAD+-dependent SIRT1/3 activity can deacetylate OPA1, promoting its GTPase activity and favoring tight cristae, creating a positive feedback loop that couples NAD+ availability to mitochondrial architecture. This loop explains why simply flooding cells with NAD+ precursors fails when the structural platform for efficient electron transfer is missing, and why tissue-specific differences in OPA1 expression or post-translational modification underlie the variable outcomes seen in human trials.

References: Cristae architecture determines supercomplex assembly and respiratory efficiency 1; Complex I oxidizes NADH to regenerate NAD+ for SIRT3/7 2; NRF1-TFAM drives mtDNA transcription and replication 3; NAD+ treatment rejuvenates senescent MSCs via Sirt-1 4; Leigh syndrome MT-ND5 mutation shows long-range allosteric coupling in Complex I 5; proton leak reduces ATP synthesis but mitigates ROS 6.